A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant gain of 126.97% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 88.79%. Over the past 30 days, the price of SILO has fallen by 112.72%. And in the last five days, it has surged by 103.29%.
SILO Pharma Inc ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $4.50 on 07/18/24, while the lowest value for the same period was recorded at $0.77 on 11/25/24.
52-week price history of SILO Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. SILO Pharma Inc’s current trading price is -55.11% away from its 52-week high, while its distance from the 52-week low is 162.34%. The stock’s price range during this period has varied between$0.77 and $4.50. The SILO Pharma Inc’s shares, which operate in the Healthcare, saw a trading volume of around 3.52 million for the day, a figure considerably higher than their average daily volume of 3.07 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
SILO Pharma Inc (SILO) has experienced a quarterly rise of 96.12% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 9.05M and boasts a workforce of 3 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.0986, with a change in price of +0.5707. Similarly, SILO Pharma Inc recorded 1,999,821 in trading volume during the last 100 days, posting a change of +40.48%.
SILO’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for SILO stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
SILO Stock Stochastic Average
SILO Pharma Inc’s raw stochastic average for the past 50 days is presently 46.57%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 46.55%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 40.51% and 38.15%, respectively.
